Avrum E Spira, MD is a pulmonologist at Boston Medical Center (BMC) with expertise in lung cancer and Chronic Obstructive Lung Disease (COPD), as well as the Director of the BU-BMC Cancer Center. Dr. Spira is also a professor of Medicine, Pathology and Bioinformatics and founding Chief of the Division of Computational Biomedicine in the Department of Medicine at Boston University Chobanian & Avedisian School of Medicine. He is the Alexander Graham Bell Professor in Health Care Entrepreneurship at Boston University and the Global Head of the Lung Cancer Initiative (LCI) at Johnson & Johnson, which is developing solutions to prevent, intercept and cure lung cancer. Dr. Spira’s research interests focus on applying genomic and bioinformatics tools to the translational study of lung cancer and COPD, with the ultimate objective of developing novel diagnostics and therapeutics that can directly impact clinical care. He has authored more than 100 peer-reviewed publications, and is a member of both the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).
  • Departments

  • Specialties

    Lung cancer, Chronic Obstructive Lung Disease (COPD)

  • Administrative Title

    Director, BU-BMC Cancer Center. Professor of Medicine, Pathology and Bioinformatics, Chief, Division of Computational Biomedicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine. Alexander Graham Bell Professor in Health Care Entrepreneurship, Boston University.